lecture 34 (allergic rhinitis) Flashcards
exam 3
what is allergic rhinitis?
- an inflammatory, IgE-mediated disease
- sensitization
- runny nose, nasal congestion, sneezing, red/watery eyes, itchy eyes and nose, nasal creases (nasal salute common in children)
- triad of atopic dermatitis, allergic rhinitis, and asthma very common
allergic vs non-allergic rhinitis
allergic:
- IgE-mediated disease
- common in adults and children
- sneezing very common plus congestion and rhinorrhea
non-allergic:
- exposure to airborne irritants (pollution, chemicals, smoke)
- primarily seen in adults
- chronic rhinorrhea
- sneezing uncommon
sensitization
allergen –> uptake and processing of allergen –> presentation of allergen fragments –> naive CD4+ –> (IL-4) TH2 cell –> (IL-4/13) B cell –> allergen-specific IgE –> binding of IgE sensitizes mast cell
re-exposure to allergen
sensitized mast cell –> histamine, leukotrienes, prostaglandins, tryptase, kinins –> early phase symptoms
TH2 cell –> cytokines/chemokines –> eosinophils and TH2 cells (infiltration of activated effector cells) –> late phase symptoms
early phase symptoms
sneezing
nasal itching
rhinorrhea
nasal congestion
late phase reactions
nasal congestion/obstruction
nasal hyperreactivity
most common allergens
grasses
trees
molds
dust/mites
animals
questions to ask patients
what symptoms are you having?
do you have any symptoms like fever, chills, or cough?
is your nasal discharge clear or colored?
how long have you had these symptoms?
do you notice a change in symptoms with the change of seasons?
does the severity of your symptoms change when you move indoors to outdoors or vice versa?
early phase reaction site of drug action
- antileukotrienes and antihistamines
- prevents vasodilation, vascular leakage, smooth muscle spasm
- prevents symptoms of sneezing, rhinorrhea, lacrimation, etc.
late phase reaction site of drug action
- corticosteroids
- inhibit release of cytokines, eosinophil activation/recruitment
- prevents eosinophil peroxidase, monobasic protein, eosinophil cationic protein, cytokines
- prevents mucosal edema, epithelial damage, leukocyte infiltration
mild intermittent treatment
oral antihistamine +/- decongestant OR intranasal antihistamine
- no preferred order
- LTRA not used for mild AR
moderate to severe intermittent treatment
OAH +/- decongestant OR INA OR INCS
- no preferred order
mild persistent treatment
OAH +/- decongestant OR INA OR INCS
- no preferred order
- LTRA not used for mild AR
moderate to severe persistent treatment
- INCS OR OAH +/- decongestant
- LTRA
- preferred order
- combo therapy if symptoms not controlled with single agent
stepwise treatment
Sx controlled but ADR are problematic –> switch to alternative agent
any AR type with severe congestion –> consider routine use of AH decongestant combo
any AR type with persistent rhinorrhea –> consider adding ipratropium NS
severe AR w/o good Sx control –> skin testing and allergy shots
AR Sx not well controlled and pt has mod/sev asthma or atopic dermatitis (rare) –> consider biologics (omalizumab/xolair, dupilumab/dupixent)